April #69 : Don't Meth Around - by Maia Szalavitz

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Geography Lessons

Mo' Money, Mo' Trouble

Cold Sore Comfort

THE BIZ OF AID$

Living Large on Small Change

Living Large on Small Change

Living Large on Small Change

O Pioneer!

Going Dental

Vax Attack

¡La Emergencia!

Monette & Merrill

Normal, New Jersey

Briefs

Milestones

Quickies

Money Pit

Cryptic 'Script

Don't Meth Around

AAT Ease

Two Strikes

LTNP? UB2

Is N-9 Deep-Sixed?

Action Zero

Mary MAC'd

Murphy's Law Breaker

Editor's Letter

Mailbox

04.09.84 The Waters of Babylon

Conflicts in Pharmaland



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

April 2001

Don't Meth Around

by Maia Szalavitz

Anti-heroin and anti-HIV meds get along about as well as Mariah and Whitney -- hardly at all.

Meth-takers: Many meds used to treat HIV may queer your body's breakdown of this common anti-heroin medication, often raising but occasionally lowering the amount of methadone in your blood. And meth can mess with levels of other pharmaceuticals -- by boosting them (and increasing side effects) or lowering them (and reducing effectiveness). So which-ever drug combo you're on, taking care to adjust your metha-done dose may mend med mêlées.

At their worst, such interactions can cause body-wracking pain. "The most significant interactions occur with NNRTIs, particularly nevirapine [Viramune] and efavirenz [Sustiva]," says Gerald Friedland, MD, director of the AIDS program at the Yale University School of Medicine. These two non-nukes increase the body's metabolism of methadone, quickly diminishing its effects, which can normally suppress cravings for 24 to 36 hours. With no methadone in the system, takers are hit with the misery of withdrawal.

Because service providers may dismiss withdrawal complaints as a drug-seeking manipulation, Friedland says, it's important that your AIDS doc contact the clinic ASAP. Other drugs that may lower methadone levels include the anti-HIV meds abacavir (Ziagen), lopinavir (Kaletra), nelfinavir (Viracept) and ritonavir (Norvir), and the anti-TB drugs rifampin and rifabutin (Mycobutin, also an anti-MAC drug). While not all meds reduce methadone levels enough to trigger obvious withdrawal signs such as vomiting or sweating, a more subtle increase in drug craving may occur. And because withdrawal's risks are more immediate and palpable than HAART's benefits, HIVers may feel more compelled to treat their heroin addiction than their HIV infection.

"Clinics shouldn't dismiss out of hand a request for an increased dose of methadone by a patient on HAART," says Friedland, who suggests slowly stepping up the methadone dose, 5 to 10 mg daily, for HIVers in withdrawal. Nor should physicians rule out a drug regimen with a convenient dosing schedule because of an interaction. "Doctors should make the meth clinic understand that an increased methadone dose is needed," Friedland says. Doctors should also be cautious when stopping a methadone-taker's HIV meds. For example, after discontinuing non-nukes, it may be wise to keep HIVers on a higher methadone dose for several weeks, because it could take that long for the non-nuke to completely leave the blood.

It's important to note that the antifungal drug ketoconazole (Nizoral), commonly prescribed to PWAs, can increase methadone blood levels. Some taking this drug may need to reduce their methadone dose, although savvy doctors use this interaction to their patient's benefit -- to increase the effectiveness of low-dose methadone in states where laws prohibit higher, more effective doses.

On the flipside, methadone doubled AZT blood levels in one study, leading to more antiviral punch but also to more side effects -- some of which, ironically, mimic withdrawal. Check with your doctor about reducing AZT doses. By contrast, methadone can reduce levels of ddI and d4T, so dosages of the nukes may need to be increased. The only way to know that dosages have been correctly adjusted is by monitoring viral load changes.

For meth users, the bottom line is pharmacokinetics -- the way the body handles a drug. When considering possible HAART choices, discussing with your doc the known methadone interactions is a step in the right direction.




[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    adoniz89
    san dimas
    California


    koffeeboss
    Tucson
    Arizona


    pevans
    San Francisco
    California


    albsur7436
    San Francisco
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.